Evidence map›Paper›PMID 19397999›Full record

ArticleFree radical biology & medicine2009

Increase in thiol oxidative stress via glutathione reductase inhibition as a novel approach to enhance cancer sensitivity to X-ray irradiation.

Yong Zhao, Teresa Seefeldt, Wei Chen, Laura Carlson, Adam Stoebner, Sarah Hanson, Ryan Foll, Duane P Matthees, Srinath Palakurthi, Xiangming Guan

Open access · greenAbstract read
In one paragraph

Article in Free radical biology & medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Redox Modulation in Therapy of Cancer: Some Pros and Cons.Antioxidants (Basel, Switzerland) · 2025
    Review
  3. Article
  4. Antioxidant Enzymes and Their Potential Use in Breast Cancer Treatment.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Article
  7. Application of nano-radiosensitizers in combination cancer therapy.Bioengineering & translational medicine · 2023
    Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yong ZhaoDepartment of Physiology, Michigan State University, East Lansing, MI 48824, USA.
Teresa Seefeldt
Wei Chen
Laura Carlson
Adam Stoebner
Sarah Hanson
Ryan Foll
Duane P Matthees
Srinath Palakurthi
Xiangming Guan
South Dakota State University · USMichigan State University · US

Funding

Inhibition of glutathione reductase and ovarian cancer drug resistance reversalR15CA120062 · NCI · SOUTH DAKOTA STATE UNIVERSITY · PI GUAN, XIANGMING · 2006 to 2006
$213k
Glutathione reductase and tumor sensitivity to radiationR15CA098810 · NCI · SOUTH DAKOTA STATE UNIVERSITY · PI GUAN, XIANGMING · 2003 to 2003
$141k
NCI NIH HHS R15 CA098810NCI NIH HHS R15 CA120062
6 · The paper itself

Abstract

Depletion of the reduced form of glutathione (GSH) has been extensively studied for its effect on sensitizing cancer to radiation. However, little is known about the effects of thiol oxidative stress created through an increase in glutathione disulfide (GSSG) on cancer sensitivity to radiation. In this study, an increase in GSSG was effectively created using 2-acetylamino-3-[4-(2-acetylamino-2-carboxyethylsulfanylthiocarbonylamino)phenylthiocarbamoylsulfanyl]propionic acid (2-AAPA), an irreversible glutathione reductase (GR) inhibitor. Our results demonstrate that the GSSG increase significantly enhanced cancer sensitivity to X-ray irradiation in four human cancer cell lines (A431, MCF7, NCI-H226, and OVCAR-3). When cells were pretreated with 2-AAPA followed by X-ray irradiation, the IC(50) values for X-ray irradiation of A431, MCF7, NCI-H226, and OVCAR-3 cells were reduced, from 24.2 +/- 2.8, 42.5 +/- 3.0, 43.0 +/- 3.6, and 27.8+/-3.5 Gy to 6.75 +/- 0.9, 8.1 +/- 1.1, 6.75 +/- 1.0, and 12.1 +/- 1.7 Gy, respectively. The synergistic effects observed from the combination of X-rays plus 2-AAPA were comparable to those from the combination of X-rays plus buthionine sulfoximine, a reference compound known to increase cancer sensitivity to radiation. The synergistic effect was correlated with an increase in cell thiol oxidative stress, which was reflected by a five-to sixfold increase in GSSG and 25% increase in total disulfides. No change in GSH or total thiols was observed as a result of GR inhibition.

Indexed as

Oxidative StressRadiation ToleranceAcetylcysteineButhionine SulfoximineCell Line, TumorCell SurvivalDrug SynergismGlutathioneGlutathione DisulfideGlutathione ReductaseHumansSulfhydryl CompoundsThiocarbamatesX-Rays2-acetylamino-3-(4-(2-acetylamino-2-carboxyethylsulfanylthiocarbonylamino)phenylthiocarbamoylsulfanyl)propionic acidAcetylcysteineButhionine SulfoximineGlutathioneGlutathione DisulfideGlutathione ReductaseSulfhydryl CompoundsThiocarbamates

Identifiers

PMID19397999
PMCPMC2745482
OpenAlexW1989603202

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.